SCHEMBL7300096

SCHEMBL7300096

[C]1Cc2sccc2CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6890381 0.69
SCHEMBL1025859 0.65
SCHEMBL2685546 0.64
SCHEMBL11088 0.59
Hydrochloric Acid SCHEMBL366688 0.59 PNMT (0.95)
SCHEMBL581897 0.58 CES1 (0.34)
Hydrochloric Acid SCHEMBL5317536 0.58 PNMT (0.91)
SCHEMBL4300042 0.58
Hydrochloric Acid SCHEMBL1427992 0.58 PNMT (0.69)
SCHEMBL31021243 0.58 PNMT (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0666260-B1 3-(2-aminoethyl)-4-3-(trifluoromethyl)benzoyl-3,4-dihydro-2H-1,4-benzoxazine derivatives, their preparation and use in therapy SYNTHELABO (FR) 1999-08-04 EP claimed
US-5550125-A BRAIN DISORDERS SYNTHELABO (FR) 1996-08-27 US claimed
US-5550125-A BRAIN DISORDERS SYNTHELABO (FR) 1996-08-27 US disclosed
US-5550125-A BRAIN DISORDERS SYNTHELABO (FR) 1996-08-27 US disclosed
EP-0666260-A1 3-(2-aminoethyl)-4-3-(trifluoromethyl)benzoyl-3,4-dihydro-2H-1,4-benzoxazine derivatives, their preparation and use in therapy SYNTHELABO (FR) 1995-08-09 EP disclosed